An Official Website of the United States Government
Company Information:
Name:
SEQUELA
Address:
6508 Old Floydsburg Road
Pewee Valley, KY 40056-
Pewee Valley, KY 40056-
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
A Uroguanylin Based ELISA for Salt Sensitivity
Award Year / Program / Phase:
2005 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Stephen L. Carrithers
Award Amount:
$403,642.00
Abstract:
DESCRIPTION: This proposal is submitted in response to the program announcement PA-03-123 "Development of diagnostic screening test for salt sensitivity (SBIR/STTR)" from the National Institute of Diabetes and Digestive and Kidney Diseases. The overall hypothesis of our laboratory is the principle… More
A Test for Salt Sensitivity in People with Essential Hypertension
Award Year / Program / Phase:
2008 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Award Amount:
$914,453.00
Abstract:
DESCRIPTION (provided by applicant): Project Summary: In Phase I we developed a model system and a prototype Salt Sensitivity Assay to establish proof-of-principle . In Phase II we propose the evaluation of the prototype that will quantitatively
measure our biomarker in the target… More
Biomarker for Early Detection of Chronic Kidney Disease
Award Year / Program / Phase:
2010 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Stephen L. Carrithers
Award Amount:
$592,427.00
Abstract:
DESCRIPTION (provided by applicant): This proposal is submitted in response to the program announcement PA-09-080, Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44]) and intende
d to be directed to the NIDDK, with a… More
BIOMARKER FOR EARLY DETECTION OF CHRONIC KIDNEY DISEASE
Award Year / Program / Phase:
2012 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Stephen L. Carrithers – 502-432-7712
Award Amount:
$1,675,105.00
Abstract:
DESCRIPTION (provided by applicant): There are an estimated 26 million Americans with early chronic kidney disease (CKD). Early diagnosis and treatment are the only cost-effective means to reverse this growing problem. NIH recognizes the challenge to diagnose CKD early during its initiation and… More